Best Peptides to Increase Testosterone

Your testosterone is governed by the hypothalamic-pituitary-gonadal (HPG) axis. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses. GnRH tells the pituitary to release luteinizing hormone (LH), and LH tells the Leydig cells in the testes to make testosterone.

Growth hormone runs on a separate circuit. GH-releasing peptides like sermorelin and CJC-1295 act on the pituitary to release growth hormone, which raises IGF-1. That pathway changes fat and muscle. It does not pull the LH lever that drives testosterone.

Think of it like two breaker switches on the same panel. One switch powers the testosterone circuit (GnRH to LH to Leydig cells). The other powers growth hormone. Flipping the GH switch lights up body composition, but the testosterone circuit stays exactly where you left it. A peptide raises your testosterone only if it acts on the HPG breaker.

Kisspeptin sits upstream of GnRH and is the master trigger for the entire reproductive axis. When kisspeptin neurons fire, they drive GnRH release, which raises LH, which raises testosterone. This is the most direct peptide mechanism for endogenous testosterone available.

In healthy men, intravenous kisspeptin-54 increased LH and raised serum testosterone, confirming kisspeptin as a potent stimulator of the gonadotropic axis (Dhillo et al., J Clin Endocrinol Metab, 2005). Subsequent human work mapped the dose-response of kisspeptin on LH pulsatility and testosterone in men (George JT et al., J Clin Endocrinol Metab, 2011). Kisspeptin also stimulated testosterone secretion in men with hypogonadotropic conditions (George JT et al., Clin Endocrinol, 2013).

The catch is duration. Most human data measures acute hours-long rises, not months of stable elevation. Kisspeptin preserves the natural pulsatile signal rather than overriding it, which is why it draws interest from men who want to protect fertility. For where it fits among male protocols, see peptides for men over 40.

Gonadorelin is synthetic GnRH, the exact hormone your hypothalamus uses to start the testosterone cascade. Delivered in pulses, it stimulates the pituitary to release LH and FSH, which raises testosterone and supports sperm production. This is established endocrinology, used clinically to test and drive the HPG axis.

Pulsatility is the rule that makes or breaks it. Natural GnRH arrives in pulses every 60 to 120 minutes. Steady continuous exposure does the opposite of what you want: it desensitizes the pituitary and shuts LH down, which is exactly how GnRH agonists are used to suppress testosterone in prostate cancer (Conn & Crowley, N Engl J Med, 1991). Pulsatile gonadorelin restored normal LH pulses and testosterone in men with hypothalamic hypogonadism (Crowley et al., Recent Prog Horm Res, 1985).

In practice, gonadorelin is dosed in small, frequent amounts (often around 100 to 200 mcg, two or more times daily) to mimic that pulse. It is widely used to maintain testicular function and fertility alongside TRT. See gonadorelin for the full profile and how to inject peptides for technique.

Gonadorelin replaced an older drug, hCG, in many men's protocols because it works one step higher on the axis. hCG mimics LH directly at the testes. Gonadorelin instead asks the pituitary to make its own LH, which keeps more of the natural feedback loop intact, which is why younger men trying to protect fertility favor it.

This is where most marketing goes wrong. Sermorelin, CJC-1295, ipamorelin, tesamorelin, and the oral secretagogue MK-677 all raise growth hormone and IGF-1. None of them reliably raises serum testosterone.

Sermorelin restores GH pulsatility through the GH-releasing hormone receptor, with no LH-driven testosterone mechanism (Walker, Clin Interv Aging, 2006). The honest breakdown lives in does sermorelin increase testosterone. CJC-1295 and ipamorelin together raise GH and IGF-1 but act outside the HPG axis, covered in CJC-1295 + ipamorelin benefits and compared in tesamorelin vs ipamorelin.

The men reaching for HPG-axis peptides usually fall into three groups. The first is younger men with secondary hypogonadism who want to raise testosterone without shutting down their own production, which exogenous testosterone tends to do. Gonadorelin and kisspeptin keep the testes signaling rather than going dormant.

The second group is men already on TRT who add gonadorelin to preserve testicular size and fertility, since standard testosterone replacement suppresses LH and sperm output. This is a maintenance role, not a testosterone-raising one, and it sits alongside the broader options in peptides for men over 50.

The third group is men chasing recovery, sleep, and fat loss who are better served by GH peptides and should stop expecting a testosterone change. None of these peptides is FDA-approved to raise testosterone in healthy men, and all carry the usual research-compound caveats around purity and sourcing. Bloodwork comes first in every case.

Scenario 1: The misdirected stack. A man with total testosterone at 320 ng/dL runs CJC-1295 + ipamorelin for 12 weeks expecting his number to climb. IGF-1 rises and waist size drops, but LH never moves and testosterone stays near 320 ng/dL. Twelve weeks lost on the wrong axis. The fix is bloodwork that includes LH and FSH before choosing a compound.

Scenario 2: Continuous instead of pulsatile. A man dosing gonadorelin once daily as a steady "boost" sees LH and testosterone fall instead of rise, because constant GnRH exposure desensitizes the pituitary the same way prostate-cancer therapy intentionally does. The fix is small, frequent pulses, and physician oversight to time them. Confirm dosing logic against the peptide dosage chart.

One sentence of context: the only column that answers "best peptide to increase testosterone" is the direct-testosterone column.

Cross-check men's protocols in peptides for men over 50 and verify draw volumes with the reconstitution calculator.

Mistake 1: Buying a GH peptide to raise testosterone. Sermorelin, CJC-1295, and MK-677 do not pull the LH lever. You can run a full 12-week cycle and see no change in serum testosterone. Choose an HPG-axis peptide if testosterone is the goal, and read does sermorelin increase testosterone first.

Mistake 2: Dosing gonadorelin continuously. Steady GnRH exposure suppresses LH instead of raising it. Pulsatile dosing is the entire point. Use small, frequent doses under medical supervision and confirm the schedule against the peptide dosage chart.

Mistake 3: Skipping LH and FSH on labs. Total testosterone alone cannot tell you whether the problem is your testes or your pituitary signal. Without LH and FSH you cannot tell whether kisspeptin or gonadorelin would even help.

Mistake 4: Treating peptides as a TRT replacement. For diagnosed hypogonadism, testosterone replacement remains the medical standard. Peptides on the HPG axis are investigational for raising testosterone, and clinical decisions belong with a physician. See peptides for men for where each option fits.